319 related articles for article (PubMed ID: 14705962)
21. Dihydropyrimidine dehydrogenase deficiency caused by a novel genomic deletion c.505_513del of DPYD.
van Kuilenburg AB; Meijer J; Gökcay G; Baykal T; Rubio-Gozalbo ME; Mul AN; de Die-Smulders CE; Weber P; Mori AC; Bierau J; Fowler B; Macke K; Sass JO; Meinsma R; Hennermann JB; Miny P; Zoetekouw L; Roelofsen J; Vijzelaar R; Nicolai J; Hennekam RC
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):509-14. PubMed ID: 20544545
[TBL] [Abstract][Full Text] [Related]
22. Dihydropyrimidine dehydrogenase deficiency in an Indian population.
Saif MW; Mattison L; Carollo T; Ezzeldin H; Diasio RB
Cancer Chemother Pharmacol; 2006 Sep; 58(3):396-401. PubMed ID: 16421754
[TBL] [Abstract][Full Text] [Related]
23. Lack of correlation between phenotype and genotype for the polymorphically expressed dihydropyrimidine dehydrogenase in a family of Pakistani origin.
Fernandez-Salguero PM; Sapone A; Wei X; Holt JR; Jones S; Idle JR; Gonzalez FJ
Pharmacogenetics; 1997 Apr; 7(2):161-3. PubMed ID: 9170156
[TBL] [Abstract][Full Text] [Related]
24. 5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency.
Boisdron-Celle M; Remaud G; Traore S; Poirier AL; Gamelin L; Morel A; Gamelin E
Cancer Lett; 2007 May; 249(2):271-82. PubMed ID: 17064846
[TBL] [Abstract][Full Text] [Related]
25. Circadian rhythm of dihydrouracil/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels.
Jiang H; Lu J; Ji J
Br J Pharmacol; 2004 Feb; 141(4):616-23. PubMed ID: 14744810
[TBL] [Abstract][Full Text] [Related]
26. Screening for dihydropyrimidine dehydrogenase deficiency: to do or not to do, that's the question.
van Kuilenburg AB
Cancer Invest; 2006 Mar; 24(2):215-7. PubMed ID: 16537192
[TBL] [Abstract][Full Text] [Related]
27. Identification of three novel mutations in the dihydropyrimidine dehydrogenase gene associated with altered pre-mRNA splicing or protein function.
Van Kuilenburg AB; Meinsma R; Beke E; Bobba B; Boffi P; Enns GM; Witt DR; Dobritzsch D
Biol Chem; 2005 Apr; 386(4):319-24. PubMed ID: 15899693
[TBL] [Abstract][Full Text] [Related]
28. ß-ureidopropionase deficiency: phenotype, genotype and protein structural consequences in 16 patients.
van Kuilenburg AB; Dobritzsch D; Meijer J; Krumpel M; Selim LA; Rashed MS; Assmann B; Meinsma R; Lohkamp B; Ito T; Abeling NG; Saito K; Eto K; Smitka M; Engvall M; Zhang C; Xu W; Zoetekouw L; Hennekam RC
Biochim Biophys Acta; 2012 Jul; 1822(7):1096-108. PubMed ID: 22525402
[TBL] [Abstract][Full Text] [Related]
29. Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism.
Wadman SK; Berger R; Duran M; de Bree PK; Stoker-de Vries SA; Beemer FA; Weits-Binnerts JJ; Penders TJ; van der Woude JK
J Inherit Metab Dis; 1985; 8 Suppl 2():113-4. PubMed ID: 3930854
[No Abstract] [Full Text] [Related]
30. Pseudomonas putida PydR, a RutR-like transcriptional regulator, represses the dihydropyrimidine dehydrogenase gene in the pyrimidine reductive catabolic pathway.
Hidese R; Mihara H; Kurihara T; Esaki N
J Biochem; 2012 Oct; 152(4):341-6. PubMed ID: 22782928
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of pyrimidine metabolism in 450 children with unspecific neurological symptoms using high-pressure liquid chromatography-electrospray ionization tandem mass spectrometry.
Schmidt C; Hofmann U; Kohlmüller D; Mürdter T; Zanger UM; Schwab M; Hoffmann GF
J Inherit Metab Dis; 2005; 28(6):1109-22. PubMed ID: 16435204
[TBL] [Abstract][Full Text] [Related]
32. Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism.
Berger R; Stoker-de Vries SA; Wadman SK; Duran M; Beemer FA; de Bree PK; Weits-Binnerts JJ; Penders TJ; van der Woude JK
Clin Chim Acta; 1984 Aug; 141(2-3):227-34. PubMed ID: 6488556
[TBL] [Abstract][Full Text] [Related]
33. FRA1E common fragile site breaks map within a 370kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD).
Hormozian F; Schmitt JG; Sagulenko E; Schwab M; Savelyeva L
Cancer Lett; 2007 Feb; 246(1-2):82-91. PubMed ID: 16556484
[TBL] [Abstract][Full Text] [Related]
34. A mild phenotype of dihydropyrimidine dehydrogenase deficiency and developmental retardation associated with a missense mutation affecting cofactor binding.
Weidensee S; Goettig P; Bertone M; Haas D; Magdolen V; Kiechle M; Meindl A; van Kuilenburg AB; Gross E
Clin Biochem; 2011 Jun; 44(8-9):722-4. PubMed ID: 21420945
[TBL] [Abstract][Full Text] [Related]
35. Increased beta-aminoisobutyric acid in rat liver with 6-azauracil and its enantiomer.
Tamaki N; Fujimoto S; Mizutani N; Mizota C
FEBS Lett; 1985 Oct; 191(1):113-6. PubMed ID: 3932092
[TBL] [Abstract][Full Text] [Related]
36. A simple and rapid high-performance liquid chromatographic (HPLC) method for 5-fluorouracil (5-FU) assay in plasma and possible detection of patients with impaired dihydropyrimidine dehydrogenase (DPD) activity.
Ciccolini J; Mercier C; Blachon MF; Favre R; Durand A; Lacarelle B
J Clin Pharm Ther; 2004 Aug; 29(4):307-15. PubMed ID: 15271097
[TBL] [Abstract][Full Text] [Related]
37. [Assay method for uracil, dihydrouracil, 5-fluorouracil and 5-fluoro-5, 6-dihydrouracil by high-performance liquid chromatography].
Nakamura A; Kikuchi K; Ohishi T; Masuike T
Gan To Kagaku Ryoho; 2004 Mar; 31(3):381-6. PubMed ID: 15045945
[TBL] [Abstract][Full Text] [Related]
38. Analysis of pyrimidine catabolism in Drosophila melanogaster using epistatic interactions with mutations of pyrimidine biosynthesis and beta-alanine metabolism.
Rawls JM
Genetics; 2006 Mar; 172(3):1665-74. PubMed ID: 16361227
[TBL] [Abstract][Full Text] [Related]
39. [A case of dihydropyrimidine dehydrogenase (DPD) deficiency with severe side effects from UFT/Uzel administration].
Kai K; Endo Y; Yoshida K; Morikawa T; Nobuhisa T; Watanabe T; Matsumoto Y; Yamada T; Doi Y; Nakashima A; Nagahiro W; Ishizuka S; Sato S; Nakashima A; Nabeyama A
Gan To Kagaku Ryoho; 2008 Feb; 35(2):339-41. PubMed ID: 18281779
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
